{"id":786837,"date":"2023-09-28T13:50:50","date_gmt":"2023-09-28T17:50:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/"},"modified":"2023-09-28T13:50:50","modified_gmt":"2023-09-28T17:50:50","slug":"kineta-announces-participation-at-october-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/","title":{"rendered":"Kineta Announces Participation at October Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SEATTLE, Sept.  28, 2023  (GLOBE NEWSWIRE) &#8212; Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today its participation in the following upcoming investor conferences in October 2023.<\/p>\n<p>\n        <u>JonesTrading 2023 Healthcare Summit <\/u><br \/>\n        <br \/>\n        <strong>Format: <\/strong>Investor meetings<br \/><strong>Location:<\/strong> Miami, FL<br \/><strong>Date:\u00a0<\/strong>October 9-11, 2023<\/p>\n<p>\n        <u>BIO Investor Forum<\/u><br \/>\n        <br \/>\n        <strong>Format: <\/strong>Corporate presentation and investor meetings<br \/><strong>Location:<\/strong> San Francisco, CA<br \/><strong>Date:<\/strong> Tuesday, October 17, 2023<br \/><strong>Time:<\/strong> 1:15-2:00 P.M. Pacific Time<\/p>\n<p>\n        <u>OPAL Group Family Office &amp; Private Wealth Management Forum West 2023<\/u><br \/>\n        <br \/>\n        <strong>Format: <\/strong>Corporate presentation and investor meetings<br \/><strong>Location:\u00a0<\/strong>Napa, CA<br \/><strong>Date:\u00a0<\/strong>Thursday, October 19, 2023<br \/><strong>Time:\u00a0<\/strong>10:50-11:10 P.M. Pacific Time<\/p>\n<p align=\"justify\">\n        <strong>About Kineta<\/strong><br \/>\n        <br \/>Kineta (Nasdaq: KA) is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients\u2019 lives. Kineta has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the major challenges with current cancer therapy. The company\u2019s immuno-oncology pipeline includes KVA12123, a novel VISTA blocking immunotherapy currently in a Phase 1\/2 clinical trial in patients with advanced solid tumors, and a preclinical monoclonal antibody targeting CD27. For more information on Kineta, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XC-tmeIFW7zG3ecYXIF2PpQ-SoqUPztlNWZUVjUP92LAf4YmmpJILlnaCnkXnHF8WVlls-arMufRUtRej40IBNTQcYtFVkpRww1Vz4cHYDA=\" rel=\"nofollow noopener\" target=\"_blank\">www.kinetabio.com<\/a>, and follow Kineta on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zWqguvWhTIsTQmG7rQPnC0WiMJG-3JfV9TqyaDddXjtWt-01zv1gP5dM3Pd6mWlb8HOXGq8OZ_dMc1WwzjKoUQ==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7J3JQMPtHQ4uF1jvEH2hnre03CfxBWYAvnptlXW9rk3A7HJkgPRDtzi2ksPlobDCYA22OU8c5Q5SG1g0yZ51cnevQckBTY1GLddz5D65JdI=\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N2mg37YuokqnKXVH1UNzck_19Sfyt3GvjlQE6wsbJ3s3p8Ek4VBafKLV4U_RYCFScQTFQ9HYf3cmm43gX6QEjlbeR3lPKWbR2BbIDBHrGVw=\" rel=\"nofollow noopener\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p>\n        <strong>FOR FURTHER INFORMATION, PLEASE CONTACT:<\/strong>\n      <\/p>\n<p>\n        <strong>Kineta, Inc.:<\/strong><br \/>\n        <br \/>Jacques Bouchy<br \/>EVP Investor Relations &amp; Business Development <br \/>+1 206-378-0400<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rgk5iU0iiart0Ndm35juuX54RQImr0GH2vy3c6CqmUm7pZMZuE47VvK5mTjXARxOguIsVky9cwObvs3Dv0pSuSTQOqfozvfNtv5dyh16eiA=\" rel=\"nofollow noopener\" target=\"_blank\">jbouchy@kineta.us<\/a><\/p>\n<p>\n        <strong>Investor Relations:<\/strong><br \/>\n        <br \/>John Mullaly<br \/>LifeSci Advisors, LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=b2Wn87QPQJLY2wNihXa9YQa5rQh7IrcXGlnoD2pFqpPWXGDJKgYrZQNsmIxVpm0P1KFbUDAc1_h-NOsHs4Vbf4oSTl1jjXHmKD3mvYO3eY15iUXn3qDy3NehaUDe-KG-\" rel=\"nofollow noopener\" target=\"_blank\">jmullaly@lifesciadvisors.com<\/a><\/p>\n<p>Source: Kineta, Inc.<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDAwMyM1ODM2NjkxIzUwMDExMDA1Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OTQ0YzZkZDctODU2Yy00N2YxLWFmZDktM2ViOTBiNzc3OWQ1LTUwMDExMDA1Mg==\/tiny\/Kineta-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE, Sept. 28, 2023 (GLOBE NEWSWIRE) &#8212; Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today its participation in the following upcoming investor conferences in October 2023. JonesTrading 2023 Healthcare Summit Format: Investor meetingsLocation: Miami, FLDate:\u00a0October 9-11, 2023 BIO Investor Forum Format: Corporate presentation and investor meetingsLocation: San Francisco, CADate: Tuesday, October 17, 2023Time: 1:15-2:00 P.M. Pacific Time OPAL Group Family Office &amp; Private Wealth Management Forum West 2023 Format: Corporate presentation and investor meetingsLocation:\u00a0Napa, CADate:\u00a0Thursday, October 19, 2023Time:\u00a010:50-11:10 P.M. Pacific Time About Kineta Kineta (Nasdaq: KA) is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients\u2019 lives. Kineta has &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Kineta Announces Participation at October Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-786837","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kineta Announces Participation at October Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kineta Announces Participation at October Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE, Sept. 28, 2023 (GLOBE NEWSWIRE) &#8212; Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today its participation in the following upcoming investor conferences in October 2023. JonesTrading 2023 Healthcare Summit Format: Investor meetingsLocation: Miami, FLDate:\u00a0October 9-11, 2023 BIO Investor Forum Format: Corporate presentation and investor meetingsLocation: San Francisco, CADate: Tuesday, October 17, 2023Time: 1:15-2:00 P.M. Pacific Time OPAL Group Family Office &amp; Private Wealth Management Forum West 2023 Format: Corporate presentation and investor meetingsLocation:\u00a0Napa, CADate:\u00a0Thursday, October 19, 2023Time:\u00a010:50-11:10 P.M. Pacific Time About Kineta Kineta (Nasdaq: KA) is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients\u2019 lives. Kineta has &hellip; Continue reading &quot;Kineta Announces Participation at October Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-28T17:50:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDAwMyM1ODM2NjkxIzUwMDExMDA1Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kineta-announces-participation-at-october-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kineta-announces-participation-at-october-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kineta Announces Participation at October Investor Conferences\",\"datePublished\":\"2023-09-28T17:50:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kineta-announces-participation-at-october-investor-conferences\\\/\"},\"wordCount\":236,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kineta-announces-participation-at-october-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkzMDAwMyM1ODM2NjkxIzUwMDExMDA1Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kineta-announces-participation-at-october-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kineta-announces-participation-at-october-investor-conferences\\\/\",\"name\":\"Kineta Announces Participation at October Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kineta-announces-participation-at-october-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kineta-announces-participation-at-october-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkzMDAwMyM1ODM2NjkxIzUwMDExMDA1Mg==\",\"datePublished\":\"2023-09-28T17:50:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kineta-announces-participation-at-october-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kineta-announces-participation-at-october-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kineta-announces-participation-at-october-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkzMDAwMyM1ODM2NjkxIzUwMDExMDA1Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkzMDAwMyM1ODM2NjkxIzUwMDExMDA1Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kineta-announces-participation-at-october-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kineta Announces Participation at October Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kineta Announces Participation at October Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Kineta Announces Participation at October Investor Conferences - Market Newsdesk","og_description":"SEATTLE, Sept. 28, 2023 (GLOBE NEWSWIRE) &#8212; Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today its participation in the following upcoming investor conferences in October 2023. JonesTrading 2023 Healthcare Summit Format: Investor meetingsLocation: Miami, FLDate:\u00a0October 9-11, 2023 BIO Investor Forum Format: Corporate presentation and investor meetingsLocation: San Francisco, CADate: Tuesday, October 17, 2023Time: 1:15-2:00 P.M. Pacific Time OPAL Group Family Office &amp; Private Wealth Management Forum West 2023 Format: Corporate presentation and investor meetingsLocation:\u00a0Napa, CADate:\u00a0Thursday, October 19, 2023Time:\u00a010:50-11:10 P.M. Pacific Time About Kineta Kineta (Nasdaq: KA) is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients\u2019 lives. Kineta has &hellip; Continue reading \"Kineta Announces Participation at October Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-28T17:50:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDAwMyM1ODM2NjkxIzUwMDExMDA1Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kineta Announces Participation at October Investor Conferences","datePublished":"2023-09-28T17:50:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/"},"wordCount":236,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDAwMyM1ODM2NjkxIzUwMDExMDA1Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/","name":"Kineta Announces Participation at October Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDAwMyM1ODM2NjkxIzUwMDExMDA1Mg==","datePublished":"2023-09-28T17:50:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDAwMyM1ODM2NjkxIzUwMDExMDA1Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkzMDAwMyM1ODM2NjkxIzUwMDExMDA1Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kineta-announces-participation-at-october-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kineta Announces Participation at October Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/786837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=786837"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/786837\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=786837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=786837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=786837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}